The significantly higher implant failure rates in maxillofacial patients, undergoing radiotherapy, might be caused by the long-term effects of reduced vascularization compromising the implantation site. An extensive preclinical animal literature and a multitude of clinical reports suggest the use of hyperbaric oxygen (HBO) therapy as it can improve the tissue vascularity. Hence, it may increase the implant survival rate by enhancing osseointegration process in such patients. The objective of this systematic review was to investigate the effectiveness of HBO therapy on dental implant survival rate in irradiated maxillofacial patients who require prosthodontic rehabilitation. An electronic search without time restrictions was undertaken in April 2016 using databases: PubMed, Google Scholar, and the Cochrane Oral Health Group Trials Register. We also tried to contact the manufacturers and researchers in the field for necessary details. Clinical human studies, on irradiated maxillofacial dental implant patients, including randomized controlled trials (RCTs), prospective controlled trials, retrospective studies, and preliminary reports were included in the study. Data collection was carried out by two of the authors' independently. The titles and abstracts of all reports were screened for the study design and type of reported intervention; all the duplicates were removed. The data search yielded 62 titles, out of which 14 articles were selected for the study by the article filtration criteria: Title/abstract/full text. Data which were extracted by two authors with any disagreement were resolved by the third author, and a meta-analysis was done using binary random-effect model. The results show decreased implant failure rate in HBO group (9.21%) compared to non-HBO group (22.44%). The potential limitations of this study are amount of radiation doses used, period lasting from radiotherapy to the placement of the implants, and follow-up period which varies for every subject of the included study, which can affect the treatment outcome. Although there are many sensitive articles published about HBO, including a number of review papers, RCTs are still lacking. According to the statistical analysis, it can be concluded that preventive HBO therapy can reduce the risk of implant failures in irradiated patients by 1.21 (relative risk) with 95% confidence interval (P < 0.001). Hence, HBO can be the effective treatment protocol for the implant treatment in irradiated maxillofacial patients. Website:
INTRODUCTION

Description of the condition
Thorough knowledge and wide field of understanding of the etiologic and risk factors of the implant failure are necessary to decrease the implant failure rates. From the last few years, implants are more commonly used in maxillofacial oral cancer patients, so whether these irradiated patient in the head and neck region are more at risk of losing dental implants or not is still unclear. Reduced tissue healing capacity leads to osteoradionecrosis, necrotic bone exposure, and pathological fracture in response to tissue trauma; thus, with reduced healing ability and osteoradionecrosis in response to injury, the implant survival rate may be reduced for the maxillofacial oral cancer patients who have undergone radiotherapy treatment. [1] [2] [3] [4] [5] [6] 
Description of the intervention
Hyperbaric oxygen (HBO) therapy and its effectiveness is still a controversial topic. [7] There are numerous studies reported for the usefulness of HBO for the treatment of osteoradionecrosis of different bone tissues. In addition to its usefulness in treating osteoradionecrosis, it may also prevent this condition. A randomized/prospective clinical trial using HBO and penicillin was carried out by Marx et al. [8] This trial demonstrated that HBO reduced the development of osteoradionecrosis after tooth removal and this reduction was statistically significant. [9] HBO therapy can be performed in multiplace or monoplace chambers. Patient is kept in a pure 100% oxygen chamber under pressure of 1.5-3 atmosphere absolute. [10] How the intervention might work?
HBO therapy increases the oxygen pressure, collagen production, and fibroblastic activity and creates a matrix for neovascularizations. [11] According to Johnsson, it also counteracts the negative effect of irradiation, stimulates the osseointegration, and improves the implant survival rate. [12] Need to do this systematic review This systematic review helps maxillofacial surgeon and prosthodontist to understand the evidence, to integrate the valid information, and to provide rational decision-making on the use of the HBO therapy for their patients. It will also help them in improving the dental implant survival rate and quality of life of such patients by providing long-term successful rehabilitation.
OBJECTIVE
The objective of the present review was to compare the implant failure rates for patients being irradiated or previously irradiated in the head and neck region and receiving HBO therapy versus irradiated patients and not receiving such therapy having follow up period of 1-2 years to 26 years.
MATERIALS AND METHODS
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs), prospective clinical trials, and retrospective studies.
Types of participants
Maxillofacial patients who have had radiotherapy and treated with dental implants for oral rehabilitation.
Types of intervention
HBO therapy compared with no HBO therapy.
Type of comparison
HBO group versus non-HBO group.
Types of outcome measures
Implant failure rates.
SEARCH STRATEGIES
An electronic search without time restrictions was undertaken in April 2016 for clinical studies comparing the implant failure rates (O), in irradiated maxillofacial patients (P), undergoing dental implant treatment either with additional HBO therapy (I) or without HBO therapy (C), using following databases: PubMed, Google Scholar, and the Cochrane Oral Health Group Trials Register. The search strategy used a combination of controlled vocabulary and free text terms.
Following keywords were used in the search box of all three databases either alone or in combination with two or more keywords (i.e., #1, #2, #3, or #1, #2, #3, #5) in an attempt not to miss any related trial, eligible to get included in the study.
Dental implants or oral implants or endosseous
implants or osseointegrated implants 2. Radiation therapy or radiotherapy or irradiation or irradiated tissues 3. Hyperbaric oxygen or hyperbaric oxygen therapy or HBO therapy or hyperbaric oxygenation 4. Dental implant failures and/or randomized controlled trials 5. HBO therapy and experimental trials 6. Irradiation, dental implants, HBO therapy, randomized controlled trials, experimental trials (Word variations had been used, i.e., radiotherapy for irradiation).
A manual search of dental implant-related journals, reference list of the identified studies, and relevant reviews on the subject was also scanned for possible additional studies. Moreover, online databases providing information about clinical trials in progress were also checked (clinicaltrials.gov; www.centerwatch.com/clinicaltrials; www.clinicalconnection.com; www.cochranelibrary.com).
Data collection and analysis
Selection of studies
The review process consisted of two phases. In the first phase, titles and abstracts of the search were initially screened by two authors for relevance and the full text of relevant abstract was obtained and accessed. Any disagreement was solved by discussion and with the third author's suggestion. The hand search of selected journals as well as search of reference of the selected studies was also done. The articles were obtained after first step of the review process using the following inclusion and exclusion criteria and were screened in the second phase, and relevant and suitable articles were isolated for further processing and data extraction. Duplicates and articles with insufficient necessary data were excluded.
Inclusion criteria's
Clinical human studies, on irradiated maxillofacial dental implant patients, including:
• (Ali et al., 1997) . The purpose of the report was to provide some preliminary data collected from a long-term, prospective investigation on the effects of HBO therapy on implant integration in the irradiated jaw. Data on the effects of various doses of irradiation to the perioral region were collected by regular clinical, radiologic, and histologic examinations.
Data extraction and management
Three review authors independently extracted data from the studies using standardized selection criteria, developed for this review. We tried to contact the authors of primary studies to request further information when data were missing or incomplete. Review authors resolved all differences by discussion. Data were excluded until further clarification became available if agreement could not be reached.
For each trial, the following data were recorded.
• Year of publication and country of origin • Details of the participants including demographic characteristics and criteria for inclusion • Details of the type of intervention • Details of the outcomes reported including method of assessment and time intervals.
Assessment of "risk of bias" in the included study
The assessment of the risk bias was conducted using the recommended approach by Cochrane reviews [ Table 1 and Graph 1] and was completed independently and in duplicate by two review authors as a part of the data extraction process. 
Results of the search for data collection
The database search yielded 62 titles, out of which 22 titles were discarded by title evaluation. Abstracts evaluation was done for the remaining 40 articles, and 6 articles were discarded on the basis of inclusion and exclusion criteria.
Full-text data were obtained for the remaining 34 articles, among which 8 articles were discarded due to insufficient data and 12 articles did not match the criteria of the study. Hence, finally, 14 articles were selected for the study [Flowchart 1].
Description of the included studies
The data obtained after the search strategy were tabulated and statistically analyzed. The results were as follows:
• Table 2 shows the required details, regarding the 14 selected studies, included in this systematic review • Table 3 shows the evidence level of the selected articles according to the study design • Table 4 shows the characteristics of the each included study.
Description of the excluded studies (with the reason for being excluded) Table 5 shows the characteristics of the excluded studies. Table 1 shows the assessment of the risk of bias of the included studies.
Risk of bias assessment
Graph 1 shows the assessment of the risk of bias of the included studies.
Effects of intervention and statistical analysis
Effect of intervention was studied for all 14 selected studies, and the implant survival rate for each group was statistically calculated [ Tables 2 and 4 ].
Results of the study
Experimental studies Table 6 shows estimated values for implant failures in HBO(+) group for an experimental study when the P value is set at P < 0.05, with the confidence interval (CI) of 95%. Table 7 shows estimated values for implant failures in non-HBO(+) group for an experimental study when the P value is set at P < 0.05, with the CI of 95%.
Forest Plot 1 shows implant failures in HBO and non-HBO group for experimental studies.
Prospective studies Table 8 shows estimated values for implant failures in HBO(−) group for three prospective studies when the same P value is set at P < 0.05, with the same CI of 95%. Table 9 shows estimated values for implant failures in non-HBO(−) group for 3 prospective studies when the P value is set at P < 0.05, with the same CI of 95%.
Forest Plot 2 shows implant failures in HBO and non-HBO group for prospective studies.
Retrospective studies Table 10 shows estimated values for implant failures in HBO(−) group for four retrospective studies when the same P value is set at P < 0.05, with the same CI of 95%. Esser and Wagner, 1997 [15] Graph 2 shows the significant difference regarding the implant failure rate in both the groups:
• Implant failure rate (%) in HBO(+) group: 9.21%
• Implant failure rate (%) in non-HBO(−) group: 22.44%
SUMMARY
The present systematic review was undertaken to compare the implant failure rates for patients being irradiated in the head and neck region and receiving HBO therapy versus non-HBO therapy. There are many scientific papers [27] written about this subject including a number of review articles, but only one RCT (Schoen et al. 2007 ) including a limited number of participants was found for this review.
CONCLUSION
According to above statistical analysis, results show that preventive HBO therapy can reduce the risk of implant failures in irradiated patients, may be due to improved vascularity which leads to reduced risk of radiation-induced Table 12 represents "Pearson's Chi-square test" which shows the total number of implants placed, failed, and survived in both the groups, with P < 0.001, which shows that significant difference exists between both the group regarding the number of implants failed and survived. [18] Methods A prospective study on dental implant survival in the irradiated jaws Participants 17 oral cancer patients (15 males, 2 females) with a mean age of 67 years (range: 47-78), treated with external radiation of the jaws, 18-228 months (mean: 88) before implant placement Intervention
The patients received 98 Nobel Biocare (Göteborg, Sweden) and 5 Astra (Astra Tech AB, Mölndal, Sweden) dental implants. Thirty-eight implants were placed in 8 maxillae and 65 implants in 14 mandibles. Eight patients (36 implants) were given more than 50 Gy of radiation (Subgroup A), and nine patients (67 implants) were given less than 50 Gy (Subgroup B) at future implant sites. Before implant placement, 6 patients (7 implants) in Subgroup A and 1 patient (2 implants) in Subgroup B received HBO treatment.
Outcome measures
Effects of radiation dose to the perioral region Trial Niimi et al., 1998 [19] Methods A survey on osseointegrated implants in irradiated jaws in nine Japanese centers and two US centers Participants 44 maxillofacial patients, treated with bone anchored prosthesis using Branemark system implants (228), following malignant tumor surgery and radiotherapy Intervention 161 implants treated with HBO therapy Control group: 67 implants (non-HBO) Outcome measures Implants buried Implants removed Implant survival rate for HBO and non-HBO group Implant survival rate, regarding radiation dose and location of the implants, implant failure related to time from placement to abutment connection Implant failure, regarding type of prosthesis Graph 2: The significant difference regarding the implant failure rate in both the groups 
